MiR-218 Exhibits Anti-Leukemia Effects by Targeting CTNND2 in Primary Acute Erythroid Leukemia HEL Cells

DOI: 10.1007/s12013-025-01722-5 Publication Date: 2025-03-18T12:47:50Z